OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer
Christian Chapa González, Karina López, Kimberly Michelle Lomelí, et al.
Life (2022) Vol. 12, Iss. 3, pp. 327-327
Open Access | Times Cited: 7
Christian Chapa González, Karina López, Kimberly Michelle Lomelí, et al.
Life (2022) Vol. 12, Iss. 3, pp. 327-327
Open Access | Times Cited: 7
Showing 7 citing articles:
Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 30
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 30
Enhanced mitochondrial co-localization of β-escin micelle and pancreatic tumor accumulation relation
Burcu Üner, Ahmet Doğan Ergin
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 104994-104994
Closed Access | Times Cited: 2
Burcu Üner, Ahmet Doğan Ergin
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 104994-104994
Closed Access | Times Cited: 2
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer
F. Gardner, Zev A. Wainberg, Christos Fountzilas, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1323-1323
Open Access
F. Gardner, Zev A. Wainberg, Christos Fountzilas, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1323-1323
Open Access
Pancreatic cancer and stem cell
Aliakbar Yousefi‐Ahmadipour, Ali Pirsadeghi, Amir Allahverdi, et al.
Elsevier eBooks (2023), pp. 363-379
Closed Access | Times Cited: 1
Aliakbar Yousefi‐Ahmadipour, Ali Pirsadeghi, Amir Allahverdi, et al.
Elsevier eBooks (2023), pp. 363-379
Closed Access | Times Cited: 1
Novel DZ‐SIM Conjugate Targets Cancer Mitochondria and Prolongs Survival in Pancreatic Ductal Adenocarcinoma
Yan Ou, Ruoxiang Wang, Gina Chia‐Yi Chu, et al.
Advanced Therapeutics (2022) Vol. 5, Iss. 10
Open Access | Times Cited: 2
Yan Ou, Ruoxiang Wang, Gina Chia‐Yi Chu, et al.
Advanced Therapeutics (2022) Vol. 5, Iss. 10
Open Access | Times Cited: 2
TTC22 as a potential prognostic marker and therapeutic target in pancreatic cancer: Insights into immune infiltration and epithelial‑mesenchymal transition
Yuntao Ding, Huizhi Wang, Wenyu Cao, et al.
Oncology Letters (2023) Vol. 27, Iss. 1
Open Access
Yuntao Ding, Huizhi Wang, Wenyu Cao, et al.
Oncology Letters (2023) Vol. 27, Iss. 1
Open Access
Efficacy and safety of nab-paclitaxel in metastatic gastric cancer: a meta-analysis
Suhana Ahmad, Lidawani Lambuk, Naveed Ahmed, et al.
Nanomedicine (2023) Vol. 18, Iss. 24, pp. 1733-1744
Closed Access
Suhana Ahmad, Lidawani Lambuk, Naveed Ahmed, et al.
Nanomedicine (2023) Vol. 18, Iss. 24, pp. 1733-1744
Closed Access
